{"id":"tau-pet-scan-using-mk-6240","safety":{"commonSideEffects":[{"rate":null,"effect":"Radiation exposure (minimal from diagnostic dose)"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL2109581","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"MK-6240 is a tau-targeted PET tracer that crosses the blood-brain barrier and selectively binds to pathological tau deposits, particularly paired helical filaments found in Alzheimer's disease and other tauopathies. The radioactive fluorine-18 label allows quantitative visualization and measurement of tau burden in the brain using PET imaging, enabling non-invasive assessment of neurodegeneration.","oneSentence":"MK-6240 is a positron emission tomography (PET) imaging agent that binds to tau protein aggregates in the brain to visualize tau pathology.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:37:31.341Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tau PET imaging in Alzheimer's disease"},{"name":"Tau PET imaging in other tauopathies and neurodegenerative diseases"}]},"trialDetails":[{"nctId":"NCT06584357","phase":"","title":"Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia","status":"RECRUITING","sponsor":"GAP Innovations, PBC","startDate":"2024-09-26","conditions":"Mild Cognitive Impairment, Alzheimer's Disease, Alzheimer's Disease, Early Onset","enrollment":1200},{"nctId":"NCT03860857","phase":"PHASE3","title":"Biomarker Exploration in Aging, Cognition and Neurodegeneration","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2018-05-01","conditions":"Alzheimer Disease, Cognitive Impairment, Cognitive Decline","enrollment":300},{"nctId":"NCT06600880","phase":"PHASE1","title":"Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-08","conditions":"Alzheimer Disease, Early Onset","enrollment":6},{"nctId":"NCT03071224","phase":"EARLY_PHASE1","title":"Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein","status":"COMPLETED","sponsor":"Invicro","startDate":"2016-06","conditions":"Alzheimer Disease, Healthy Volunteers","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":97,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["tau PET"],"phase":"phase_3","status":"active","brandName":"Tau PET scan using MK-6240","genericName":"Tau PET scan using MK-6240","companyName":"University of California, Irvine","companyId":"university-of-california-irvine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MK-6240 is a positron emission tomography (PET) imaging agent that binds to tau protein aggregates in the brain to visualize tau pathology. Used for Tau PET imaging in Alzheimer's disease, Tau PET imaging in other tauopathies and neurodegenerative diseases.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}